Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes
Annals of Internal Medicine, 09/15/09
Kelly TK et al. – Intensive glucose control reduced the risk for some cardiovascular disease outcomes (such as nonfatal myocardial infarction), did not reduce the risk for cardiovascular death or all–cause mortality, and increased the risk for severe hypoglycemia.
Methods- Studies were retrieved by systematically searching the MEDLINE database (January 1950 to April 2009) with no language restrictions.
- Two independent reviewers screened abstracts or full–text articles to identify randomized trials that compared clinical outcomes in patients with type 2 diabetes receiving intensive glucose control and those receiving conventional glucose control.
- Two investigators independently abstracted data on study variables and outcomes, including severe hypoglycemia, cardiovascular disease, and all–cause mortality.
- 5 trials involving 27 802 adults were included.
- Intensive glucose targets were lower in the 3 most recent trials.
- Summary analyses showed that compared with conventional control, intensive glucose control reduced the risk for cardiovascular disease but not cardiovascular death or all–cause mortality.
- Intensive glucose control increased the risk for severe hypoglycemia.
- Limitation: Summary rather than individual data were pooled across trials.
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Omega-3 fatty acids and heart failure
Current Atherosclerosis Reports, 11/12/09
Vitamin D and cardiovascular disease
Current Atherosclerosis Reports, 11/12/09
Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Nutritional supplements and serum lipids: Does anything work
Current Atherosclerosis Reports, 11/16/09
Carbohydrate-restricted diets for obesity and related diseases: An update
Current Atherosclerosis Reports, 11/17/09
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09
Today in Preventive Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/21/09
Omega-3 fatty acids and heart failure
Current Atherosclerosis Reports, 11/12/09
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 11/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


